Simtra BioPharma Solutions has opened Building H, a more than $250 million expansion of its Bloomington, Indiana manufacturing campus. The CDMO, focused exclusively on sterile injectables, marked the milestone with a ribbon-cutting ceremony on November 9 attended by Indiana Governor Mike Braun, Bloomington Mayor Kerry Thomson and company leaders.
The 153,000-square-foot Building H adds new prefilled syringe, vial and lyophilization capabilities, expanding Simtra's ability to support a broad range of sterile injectable products.
CEO Franco Negron said Building H represents more than additional manufacturing capacity and is an important milestone in the growth strategy Simtra is executing. He said the company is investing in the capacity, technology and infrastructure customers need to develop and manufacture increasingly complex sterile injectable medicines, with major investments in Bloomington and Halle, Germany, strengthening its global network.
Building H is part of Simtra's broader growth strategy, which includes more than $125 million invested in expanded manufacturing capacity in Halle and an initial investment of more than $150 million at its Bloomington Park Campus. Across its U.S. and European network, Simtra plans to grow from 11 filling lines to 18 by 2027 to support customer demand.
COO Ray Guidotti said customers are planning years ahead and need manufacturing partners that can do the same, and that the investments give customers greater flexibility in where and how they manufacture and a foundation that can scale as their programs grow.
The expansion is also expected to create hundreds of jobs in Bloomington.